PURE BIOSCIENCE, INC. Net Cash Provided by (Used in) Financing Activities in USD from Q3 2010 to 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Pure Bioscience, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2010 to 2025.
  • Pure Bioscience, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending October 31, 2024 was $500K, a 36.3% decline year-over-year.
  • Pure Bioscience, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $2M, a 12% increase from 2024.
  • Pure Bioscience, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $1.79M, a 75.9% increase from 2023.
  • Pure Bioscience, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1.02M, a 71% decline from 2022.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

PURE BIOSCIENCE, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $500K -$285K -36.3% Aug 1, 2024 Oct 31, 2024 10-Q 2024-12-16
Q3 2023 $785K Aug 1, 2023 Oct 31, 2023 10-Q 2024-12-16
Q3 2019 $830K -$163K -16.4% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-15
Q3 2018 $993K -$1.64M -62.3% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-13
Q3 2017 $2.63M +$2.63M Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-13
Q3 2016 $0 -$6M -100% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-14
Q3 2015 $6M -$1.49M -19.9% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-14
Q3 2014 $7.49M +$4.19M +127% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-10
Q3 2013 $3.31M +$411K +14.2% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-11
Q3 2012 $2.89M +$2.17M +302% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-12
Q3 2011 $720K -$2.03M -73.8% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-11
Q3 2010 $2.75M Aug 1, 2010 Oct 31, 2010 10-Q/A 2011-12-22

PURE BIOSCIENCE, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $2M +$215K +12% Aug 1, 2024 Jul 31, 2025 10-K 2025-10-29
2024 $1.79M +$770K +75.9% Aug 1, 2023 Jul 31, 2024 10-K 2025-10-29
2023 $1.02M -$2.49M -71% Aug 1, 2022 Jul 31, 2023 10-K 2024-10-29
2022 $3.5M +$3.26M +1364% Aug 1, 2021 Jul 31, 2022 10-K 2023-10-30
2021 $239K -$2.59M -91.6% Aug 1, 2020 Jul 31, 2021 10-K 2022-10-28
2020 $2.83M +$280K +11% Aug 1, 2019 Jul 31, 2020 10-K 2021-10-28
2019 $2.55M -$582K -18.6% Aug 1, 2018 Jul 31, 2019 10-K 2020-10-08
2018 $3.13M +$1.9M +154% Aug 1, 2017 Jul 31, 2018 10-K 2019-10-30
2017 $1.23M -$8.04M -86.7% Aug 1, 2016 Jul 31, 2017 10-K 2018-10-25
2016 $9.27M +$1.86M +25.2% Aug 1, 2015 Jul 31, 2016 10-K 2017-10-26
2015 $7.41M +$979K +15.2% Aug 1, 2014 Jul 31, 2015 10-K 2016-10-27
2014 $6.43M +$3.14M +95.3% Aug 1, 2013 Jul 31, 2014 10-K 2015-10-28
2013 $3.29M -$1.63M -33.1% Aug 1, 2012 Jul 31, 2013 10-K 2013-10-24
2012 $4.92M -$1.05M -17.6% Aug 1, 2011 Jul 31, 2012 10-K 2013-10-24
2011 $5.97M Aug 1, 2010 Jul 31, 2011 10-K 2012-10-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.